Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 21.20 | 40.04 | 5.78 | 1.71 | 0.43 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 9.87 | 20.58 | 2.11 | 1.27 | 1.13 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 8.01 | 19.01 | 8.01 | 5.00 | 1.00 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 2.68 | 15.20 | 2.68 | 0.45 | 0.89 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 4.36 | 21.81 | 1.74 | 0.87 | 0.00 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 30.40 | 55.73 | 7.60 | 2.53 | 2.53 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 291.22 | 150.98 | 386.61 | 46.75 | 5.05 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 18.81 | 151.75 | 5.48 | 0.78 | 0.52 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 1002.59 | 401.77 | 307.41 | 19.17 | 10.08 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 1595.17 | 725.02 | 905.75 | 59.31 | 5.58 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 251.64 | 247.06 | 35.82 | 22.28 | 5.68 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 216.29 | 252.16 | 28.75 | 8.18 | 5.01 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 670.57 | 149.51 | 229.59 | 17.20 | 7.43 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 288.32 | 112.34 | 150.12 | 11.93 | 11.27 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 219.18 | 150.60 | 122.36 | 28.24 | 12.10 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 270.01 | 191.05 | 148.87 | 30.74 | 18.08 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 254.15 | 184.77 | 122.69 | 27.75 | 18.26 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 397.67 | 207.86 | 174.68 | 30.25 | 15.61 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 399.77 | 284.90 | 324.67 | 58.24 | 7.26 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 549.58 | 274.58 | 691.56 | 60.18 | 10.40 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 131.65 | 236.03 | 21.94 | 13.17 | 2.19 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 165.44 | 135.96 | 20.04 | 11.74 | 7.73 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 534.91 | 230.50 | 234.60 | 24.77 | 6.43 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 156.68 | 134.21 | 40.30 | 16.82 | 9.92 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 265.54 | 358.23 | 85.43 | 159.70 | 2.06 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 318.30 | 353.28 | 115.60 | 171.75 | 2.71 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 301.78 | 361.60 | 105.79 | 166.32 | 2.05 |
Basophils, donor1.CNhs12546.12241-129G9 | 16.13 | 97.55 | 9.05 | 31.08 | 0.79 |
Basophils, donor2.CNhs12563.12242-129H1 | 11.51 | 92.12 | 3.45 | 14.97 | 1.15 |
Basophils, donor3.CNhs12575.12243-129H2 | 32.67 | 92.27 | 11.92 | 38.08 | 0.31 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 349.38 | 432.13 | 86.43 | 41.37 | 9.19 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 566.27 | 472.89 | 117.17 | 34.94 | 3.61 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 732.85 | 560.92 | 152.34 | 30.69 | 8.13 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 389.20 | 302.04 | 164.46 | 66.31 | 9.61 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 127.67 | 197.47 | 86.72 | 39.10 | 4.12 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 98.65 | 227.54 | 10.28 | 21.73 | 3.52 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 17.73 | 61.49 | 14.40 | 29.92 | 2.77 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 22.46 | 138.58 | 14.84 | 37.30 | 1.00 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 18.01 | 71.83 | 7.38 | 20.62 | 0.87 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 4.70 | 27.77 | 2.24 | 13.66 | 0.67 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 4.21 | 36.92 | 3.24 | 13.93 | 0.32 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 4.89 | 32.45 | 1.55 | 16.23 | 0.77 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 77.21 | 139.44 | 44.35 | 49.29 | 0.15 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 135.66 | 208.59 | 80.87 | 79.35 | 0.38 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 103.10 | 153.31 | 68.41 | 87.82 | 0.49 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 120.17 | 176.18 | 56.02 | 46.49 | 0.00 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 175.57 | 219.97 | 102.38 | 71.54 | 1.23 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 132.55 | 150.83 | 80.83 | 64.73 | 0.62 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 137.80 | 135.79 | 44.30 | 24.45 | 0.86 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 111.43 | 149.60 | 57.38 | 40.47 | 0.26 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 78.51 | 112.57 | 45.17 | 29.32 | 0.24 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 79.64 | 125.14 | 36.20 | 19.65 | 0.00 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 61.32 | 155.56 | 38.73 | 43.25 | 0.00 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 70.42 | 125.95 | 43.34 | 36.57 | 0.00 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 134.78 | 174.31 | 59.48 | 54.21 | 0.56 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 175.48 | 193.49 | 111.62 | 65.22 | 1.09 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 99.10 | 115.51 | 49.89 | 44.72 | 0.67 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 163.75 | 169.26 | 70.71 | 40.71 | 0.31 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 140.25 | 234.92 | 90.18 | 70.60 | 0.96 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 138.74 | 150.88 | 76.08 | 60.74 | 0.64 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 29.03 | 111.82 | 16.82 | 22.10 | 0.33 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 72.41 | 168.75 | 45.08 | 45.48 | 1.00 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 45.61 | 111.67 | 32.39 | 46.88 | 0.00 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 123.34 | 168.03 | 58.04 | 43.53 | 0.58 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 174.19 | 205.96 | 100.99 | 62.98 | 0.57 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 174.39 | 196.81 | 95.91 | 62.28 | 0.62 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 124.62 | 125.37 | 49.24 | 25.88 | 0.50 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 107.95 | 182.52 | 57.88 | 45.37 | 0.00 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 108.16 | 127.92 | 49.74 | 38.66 | 0.22 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 67.20 | 170.72 | 27.24 | 27.24 | 0.61 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 107.54 | 248.59 | 77.71 | 50.82 | 0.00 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 89.88 | 136.40 | 43.67 | 34.81 | 0.32 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 2.11 | 49.86 | 0.42 | 4.86 | 0.21 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 3.83 | 46.56 | 0.21 | 8.08 | 0.64 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 3.14 | 37.32 | 0.42 | 7.34 | 0.42 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 2.13 | 59.08 | 0.79 | 6.74 | 0.11 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 2.85 | 59.47 | 0.45 | 7.81 | 0.00 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 2.57 | 78.92 | 0.32 | 11.89 | 0.16 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 1.14 | 15.68 | 0.00 | 2.57 | 0.00 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 1.79 | 31.23 | 0.00 | 4.77 | 0.20 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 1.64 | 27.03 | 0.00 | 5.48 | 0.18 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 5.28 | 35.20 | 5.28 | 12.32 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 13.65 | 40.96 | 2.18 | 8.19 | 0.55 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 9.78 | 55.15 | 0.89 | 9.78 | 0.89 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 13.66 | 36.27 | 3.84 | 8.96 | 0.43 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 12.01 | 69.27 | 2.40 | 8.01 | 1.20 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 8.05 | 36.21 | 0.57 | 13.79 | 0.57 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 15.20 | 52.22 | 2.64 | 8.59 | 0.66 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 8.59 | 41.02 | 1.91 | 5.72 | 0.00 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 14.80 | 60.34 | 4.55 | 10.25 | 1.14 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 11.74 | 78.69 | 7.63 | 22.32 | 0.59 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 9.56 | 73.40 | 4.59 | 10.70 | 0.76 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 22.47 | 140.10 | 1.32 | 1.32 | 3.97 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 47.64 | 209.07 | 5.61 | 11.77 | 1.68 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 140.38 | 189.64 | 9.48 | 25.55 | 6.06 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 16.72 | 84.98 | 2.16 | 0.98 | 2.16 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 14.93 | 137.55 | 3.93 | 1.57 | 1.18 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 12.34 | 106.09 | 3.29 | 1.23 | 2.47 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 10.70 | 75.74 | 2.51 | 0.84 | 4.68 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 7.17 | 73.01 | 0.65 | 1.30 | 3.26 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 4.73 | 58.23 | 0.47 | 0.47 | 3.79 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 9.74 | 91.57 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 14.26 | 103.95 | 1.89 | 1.78 | 2.01 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 5.60 | 46.25 | 1.77 | 0.59 | 0.59 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 7.53 | 57.38 | 0.66 | 0.44 | 0.89 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 8.39 | 84.22 | 1.35 | 0.54 | 0.54 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 23.95 | 90.82 | 3.46 | 0.77 | 3.20 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 26.14 | 76.60 | 2.99 | 1.30 | 2.60 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 25.82 | 108.36 | 3.45 | 2.14 | 4.44 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 24.60 | 114.96 | 2.76 | 2.49 | 5.25 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 15.36 | 108.39 | 1.74 | 0.58 | 4.06 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 11.86 | 131.38 | 1.63 | 0.30 | 5.49 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 6.69 | 107.28 | 0.80 | 0.27 | 5.08 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 9.41 | 104.54 | 0.00 | 0.00 | 4.18 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 28.67 | 112.06 | 2.15 | 2.49 | 3.06 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 4.60 | 62.85 | 1.53 | 0.38 | 2.68 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 5.84 | 64.95 | 1.72 | 0.00 | 3.44 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 12.40 | 109.30 | 2.02 | 0.76 | 3.04 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 15.61 | 72.95 | 1.59 | 0.96 | 2.55 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 11.07 | 47.53 | 0.65 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 4.75 | 61.78 | 1.90 | 0.95 | 1.90 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 7.23 | 72.13 | 0.90 | 1.36 | 2.11 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 8.06 | 83.58 | 1.66 | 0.51 | 2.30 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 9.99 | 73.71 | 1.25 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 16.10 | 87.13 | 1.18 | 0.71 | 0.71 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 9.03 | 49.27 | 1.64 | 0.00 | 1.64 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 6.85 | 57.86 | 2.22 | 2.42 | 2.02 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 10.70 | 82.10 | 3.74 | 5.88 | 1.07 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 11.88 | 66.47 | 2.75 | 3.04 | 1.45 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 12.19 | 24.38 | 0.00 | 4.88 | 4.88 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 208.59 | 173.71 | 43.60 | 10.06 | 9.39 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 83.24 | 86.05 | 14.45 | 3.20 | 4.60 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 24.22 | 33.61 | 16.63 | 5.06 | 1.81 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 32.59 | 92.75 | 11.03 | 2.51 | 2.51 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 24.33 | 51.42 | 16.66 | 2.46 | 1.88 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 34.99 | 66.80 | 12.72 | 10.34 | 1.59 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 21.90 | 49.64 | 16.06 | 1.95 | 1.46 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 397.80 | 209.11 | 65.99 | 15.69 | 4.16 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 334.59 | 192.90 | 91.35 | 17.74 | 3.77 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 395.17 | 166.97 | 74.75 | 14.23 | 3.25 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 22.33 | 49.31 | 4.52 | 5.76 | 3.08 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 745.71 | 600.36 | 98.00 | 36.43 | 19.31 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 447.91 | 350.02 | 62.66 | 24.47 | 8.16 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 8.11 | 23.69 | 3.25 | 56.80 | 0.65 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 8.71 | 36.04 | 6.27 | 61.29 | 0.87 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 8.91 | 40.95 | 4.39 | 58.63 | 0.93 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 17.65 | 50.32 | 5.96 | 56.05 | 3.10 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 14.30 | 57.77 | 1.72 | 43.47 | 4.58 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 9.66 | 50.15 | 3.34 | 49.78 | 4.09 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 1039.33 | 176.30 | 1353.77 | 53.47 | 15.30 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 668.40 | 184.09 | 1105.40 | 61.94 | 17.20 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 663.04 | 181.90 | 694.98 | 39.23 | 6.25 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 369.15 | 208.60 | 1613.95 | 44.66 | 3.96 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 724.06 | 195.07 | 755.10 | 37.75 | 6.71 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 882.30 | 243.20 | 1007.48 | 40.44 | 3.85 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 966.81 | 226.34 | 1197.12 | 43.26 | 2.93 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 355.58 | 80.37 | 327.41 | 18.09 | 2.58 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 227.69 | 105.66 | 252.59 | 13.52 | 3.20 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 119.83 | 101.42 | 71.30 | 6.36 | 2.34 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 339.18 | 224.78 | 195.37 | 24.57 | 6.85 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 357.33 | 181.71 | 644.71 | 34.21 | 3.80 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 401.73 | 267.74 | 51.99 | 7.32 | 3.42 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 354.43 | 163.24 | 409.94 | 27.21 | 3.68 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 307.04 | 220.36 | 327.30 | 23.49 | 4.05 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 796.91 | 166.54 | 595.72 | 19.02 | 2.86 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 954.03 | 183.44 | 825.59 | 21.33 | 4.04 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 1041.32 | 191.44 | 579.95 | 21.51 | 2.70 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 660.79 | 128.79 | 1928.72 | 62.86 | 12.27 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 745.17 | 208.84 | 2853.49 | 99.67 | 2.85 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 782.45 | 153.71 | 1217.19 | 42.69 | 6.60 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 46.12 | 181.86 | 5.27 | 13.18 | 0.00 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 19.39 | 139.60 | 3.88 | 7.76 | 3.88 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 458.33 | 356.72 | 52.77 | 31.40 | 11.77 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 42.74 | 58.15 | 23.36 | 7.95 | 1.49 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 137.90 | 95.86 | 108.40 | 19.37 | 4.18 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 63.82 | 27.67 | 34.16 | 5.03 | 2.78 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 38.15 | 43.03 | 58.80 | 8.89 | 6.60 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 318.14 | 132.65 | 482.35 | 37.59 | 7.45 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 103.73 | 90.27 | 80.18 | 11.21 | 3.92 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 157.99 | 244.46 | 97.14 | 11.74 | 4.27 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 93.73 | 111.74 | 47.61 | 17.02 | 7.65 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 189.84 | 133.51 | 43.88 | 6.22 | 5.29 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 157.21 | 121.37 | 75.17 | 10.10 | 4.04 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 196.32 | 109.36 | 103.47 | 11.12 | 4.25 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 49.95 | 143.18 | 19.22 | 7.72 | 2.27 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 65.68 | 119.27 | 7.49 | 1.15 | 1.15 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 742.56 | 294.54 | 1743.35 | 73.34 | 10.08 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 578.43 | 119.87 | 1859.85 | 83.66 | 26.85 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 656.61 | 272.12 | 2122.16 | 116.38 | 16.54 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 720.04 | 182.78 | 2267.58 | 94.30 | 20.33 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 652.11 | 241.45 | 558.64 | 28.77 | 8.10 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 455.02 | 193.28 | 843.20 | 46.30 | 5.18 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 464.61 | 192.70 | 963.35 | 45.08 | 4.21 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 533.25 | 127.80 | 1141.22 | 48.59 | 8.37 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 659.13 | 129.47 | 3098.62 | 85.62 | 5.16 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 488.94 | 188.26 | 677.09 | 26.66 | 10.02 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 70.09 | 54.65 | 53.46 | 19.01 | 5.94 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 56.62 | 97.67 | 73.69 | 8.90 | 8.16 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 1122.23 | 898.33 | 690.81 | 65.53 | 15.47 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 736.58 | 752.39 | 214.15 | 33.06 | 23.71 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 461.41 | 125.24 | 1691.10 | 63.29 | 6.40 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 643.99 | 171.16 | 2932.78 | 80.08 | 7.13 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 511.18 | 163.47 | 1104.38 | 63.72 | 8.59 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 124.23 | 95.26 | 135.21 | 21.95 | 10.97 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 75.40 | 77.85 | 105.43 | 12.87 | 2.76 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 102.16 | 102.16 | 128.45 | 16.98 | 13.22 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 238.32 | 96.87 | 106.51 | 9.76 | 2.16 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 35.52 | 41.08 | 50.95 | 8.79 | 2.87 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 49.12 | 63.21 | 20.72 | 4.70 | 3.84 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 96.43 | 121.86 | 40.48 | 10.17 | 4.87 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 49.52 | 47.41 | 51.02 | 17.41 | 4.20 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 128.20 | 153.14 | 95.63 | 17.93 | 4.02 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 17.00 | 23.45 | 16.49 | 4.64 | 0.77 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 64.21 | 88.96 | 46.53 | 9.12 | 4.65 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 99.41 | 44.73 | 60.25 | 12.49 | 2.87 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 52.03 | 84.19 | 34.20 | 11.79 | 2.34 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 31.81 | 33.83 | 29.79 | 5.30 | 1.51 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 72.72 | 145.16 | 32.03 | 7.00 | 2.95 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 65.63 | 139.18 | 55.77 | 7.76 | 6.47 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 23.43 | 42.25 | 26.98 | 11.01 | 1.07 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 86.45 | 91.99 | 73.15 | 19.65 | 7.25 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 132.26 | 91.22 | 186.01 | 34.76 | 6.44 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 294.53 | 121.75 | 51.99 | 17.39 | 2.90 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 129.83 | 97.92 | 21.27 | 9.27 | 1.91 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 276.19 | 123.90 | 71.41 | 18.36 | 5.45 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 598.28 | 522.17 | 32.45 | 6.83 | 5.24 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 311.58 | 465.18 | 35.52 | 7.16 | 5.04 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 397.50 | 443.40 | 29.63 | 6.97 | 4.88 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 451.65 | 347.68 | 36.80 | 9.43 | 3.21 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 1144.02 | 671.93 | 59.30 | 10.85 | 7.06 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 485.78 | 541.26 | 22.99 | 8.03 | 4.01 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 142.37 | 107.95 | 65.71 | 25.03 | 6.26 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 139.58 | 135.72 | 45.67 | 18.01 | 4.50 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 958.66 | 296.99 | 1403.45 | 154.71 | 15.19 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 326.92 | 240.54 | 64.55 | 6.97 | 7.89 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 390.54 | 234.61 | 142.93 | 14.44 | 12.27 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 153.44 | 118.43 | 36.91 | 30.17 | 7.81 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 129.81 | 128.97 | 35.91 | 29.84 | 10.62 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 143.88 | 132.56 | 33.50 | 31.09 | 6.51 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 170.62 | 114.82 | 34.19 | 28.68 | 9.60 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 140.75 | 140.31 | 40.53 | 28.32 | 9.15 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 153.51 | 140.46 | 40.10 | 28.71 | 9.25 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 168.81 | 130.92 | 36.00 | 27.37 | 7.42 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 143.44 | 140.89 | 41.60 | 29.24 | 10.20 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 148.90 | 160.44 | 38.47 | 27.32 | 7.69 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 275.33 | 210.37 | 155.75 | 16.98 | 6.64 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 699.81 | 502.07 | 405.30 | 39.27 | 9.82 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 146.52 | 148.99 | 23.87 | 6.59 | 5.76 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 149.95 | 221.98 | 19.11 | 5.88 | 7.35 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 0.00 | 7.61 | 0.00 | 1.27 | 0.00 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 1.97 | 16.71 | 0.98 | 0.00 | 0.98 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 1.18 | 5.32 | 0.00 | 1.18 | 0.00 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 62.25 | 115.66 | 9.71 | 2.65 | 13.24 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 83.14 | 81.05 | 3.69 | 3.94 | 4.18 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 532.20 | 162.47 | 184.78 | 29.51 | 10.12 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 167.37 | 267.13 | 17.78 | 12.84 | 4.17 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 654.18 | 600.23 | 96.67 | 26.98 | 6.74 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 486.26 | 277.36 | 71.38 | 15.88 | 4.52 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 570.62 | 351.93 | 44.81 | 17.59 | 7.50 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 466.88 | 310.17 | 732.74 | 63.86 | 5.86 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 508.53 | 198.63 | 1883.32 | 84.23 | 4.16 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 562.89 | 278.56 | 386.81 | 28.87 | 7.22 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 1120.70 | 294.46 | 79.76 | 16.35 | 11.13 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 116.70 | 93.11 | 25.13 | 5.99 | 2.58 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 224.92 | 179.30 | 125.89 | 10.68 | 4.19 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 191.68 | 194.45 | 92.13 | 10.19 | 2.31 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 117.96 | 121.38 | 52.70 | 4.95 | 0.76 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 35.56 | 73.49 | 5.53 | 3.95 | 5.53 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 37.77 | 61.81 | 5.15 | 5.15 | 3.43 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 7.39 | 30.28 | 2.71 | 20.93 | 0.25 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 31.36 | 56.63 | 10.30 | 55.46 | 2.34 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 34.78 | 72.38 | 12.19 | 41.62 | 3.12 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 29.99 | 31.87 | 5.62 | 6.56 | 2.81 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 19.15 | 55.77 | 4.87 | 5.38 | 1.34 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 100.80 | 143.05 | 19.71 | 10.92 | 3.26 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 125.65 | 108.37 | 25.52 | 11.55 | 7.25 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 102.30 | 150.55 | 25.29 | 12.79 | 7.85 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 228.11 | 213.54 | 48.31 | 37.19 | 12.65 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 165.53 | 91.14 | 11.82 | 15.77 | 0.49 |
Mast cell, donor1.CNhs12566.11563-120D6 | 15.94 | 40.33 | 0.53 | 1.32 | 0.79 |
Mast cell, donor2.CNhs12594.11565-120D8 | 20.32 | 59.92 | 2.28 | 0.83 | 1.04 |
Mast cell, donor3.CNhs12593.11566-120D9 | 7.64 | 49.43 | 1.30 | 0.58 | 0.29 |
Mast cell, donor4.CNhs12592.11567-120E1 | 19.44 | 47.97 | 2.90 | 0.38 | 0.88 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 98.80 | 101.47 | 67.50 | 44.64 | 5.52 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 132.17 | 205.51 | 128.35 | 109.25 | 15.66 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 53.92 | 255.53 | 37.51 | 71.50 | 18.75 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 112.91 | 189.89 | 130.02 | 97.51 | 3.42 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 126.79 | 111.16 | 76.81 | 30.03 | 4.11 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 94.01 | 169.39 | 22.83 | 32.44 | 4.81 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 52.88 | 195.79 | 10.29 | 23.72 | 8.00 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 446.17 | 321.03 | 1327.97 | 148.46 | 9.08 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 82.40 | 138.20 | 74.11 | 20.05 | 6.98 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 521.51 | 208.13 | 1337.54 | 110.45 | 2.49 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 175.81 | 126.43 | 32.84 | 9.82 | 5.43 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 2317.61 | 1859.81 | 164.52 | 57.23 | 25.04 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 380.39 | 246.83 | 353.34 | 26.20 | 4.23 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 97.87 | 81.38 | 26.06 | 7.45 | 4.79 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 92.57 | 72.81 | 72.81 | 17.68 | 5.20 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 1034.23 | 290.90 | 873.73 | 50.93 | 5.92 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 1083.73 | 280.86 | 1421.33 | 72.34 | 7.09 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 1323.59 | 286.67 | 1456.00 | 70.87 | 7.19 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 80.07 | 215.61 | 7.15 | 4.43 | 3.43 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 95.50 | 206.74 | 2.71 | 1.63 | 2.17 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 317.77 | 240.39 | 111.14 | 15.64 | 10.70 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 344.95 | 146.91 | 258.31 | 30.62 | 5.21 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 77.83 | 141.45 | 6.04 | 2.49 | 2.13 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 215.41 | 175.02 | 68.90 | 16.63 | 7.92 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 294.81 | 92.24 | 59.38 | 8.14 | 8.14 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 293.71 | 109.81 | 78.44 | 20.05 | 13.07 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 408.79 | 147.66 | 71.78 | 12.30 | 7.10 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 8.51 | 88.79 | 4.86 | 40.14 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 9.54 | 65.80 | 3.52 | 44.70 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 16.87 | 84.33 | 10.54 | 46.38 | 2.11 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 86.26 | 76.92 | 72.85 | 17.97 | 1.92 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 13.78 | 62.03 | 8.04 | 1.15 | 2.30 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 476.41 | 360.87 | 415.07 | 98.42 | 29.95 |
Myoblast, donor1.CNhs10870.11241-116D8 | 107.57 | 60.52 | 58.64 | 14.19 | 5.07 |
Myoblast, donor2.CNhs11965.11322-117D8 | 380.54 | 161.92 | 319.93 | 29.18 | 14.18 |
Myoblast, donor3.CNhs11908.11398-118D3 | 56.05 | 55.87 | 25.61 | 9.31 | 5.37 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 86.31 | 123.07 | 9.42 | 8.29 | 4.26 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 10.25 | 57.53 | 3.74 | 3.15 | 0.99 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 12.08 | 84.53 | 4.74 | 4.53 | 2.37 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 9.63 | 62.63 | 3.08 | 2.95 | 1.28 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 173.55 | 189.05 | 66.57 | 25.92 | 4.32 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 188.70 | 240.76 | 96.30 | 19.52 | 9.11 |
Neurons, donor1.CNhs12338.11494-119E9 | 70.37 | 142.29 | 36.34 | 13.92 | 3.87 |
Neurons, donor2.CNhs12726.11574-120E8 | 102.69 | 109.72 | 59.30 | 11.56 | 0.67 |
Neurons, donor3.CNhs13815.11655-122E8 | 97.60 | 139.71 | 37.00 | 10.84 | 2.55 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 3.75 | 41.94 | 1.50 | 2.25 | 0.00 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 5.98 | 56.84 | 0.00 | 2.99 | 0.00 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 4.97 | 35.64 | 0.41 | 1.66 | 0.41 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 394.33 | 188.82 | 23.92 | 4.17 | 3.93 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 625.71 | 311.61 | 123.04 | 11.50 | 8.50 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 533.31 | 232.75 | 209.15 | 12.48 | 10.85 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 24.96 | 65.09 | 14.77 | 6.45 | 1.87 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 45.32 | 75.30 | 33.19 | 11.95 | 2.32 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 28.86 | 55.98 | 13.72 | 2.52 | 0.63 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 54.12 | 89.50 | 25.30 | 3.98 | 1.64 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 211.57 | 210.06 | 84.87 | 11.74 | 10.83 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 86.41 | 100.06 | 40.93 | 6.82 | 11.37 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 310.42 | 277.31 | 220.40 | 19.66 | 10.35 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 282.96 | 164.73 | 243.77 | 30.55 | 13.95 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 560.48 | 188.61 | 353.80 | 43.88 | 11.62 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 427.64 | 171.07 | 275.94 | 27.72 | 11.64 |
Pericytes, donor1.CNhs11317.11491-119E6 | 238.88 | 421.36 | 112.39 | 22.71 | 10.38 |
Pericytes, donor2.CNhs12079.11571-120E5 | 87.16 | 210.69 | 31.91 | 12.01 | 3.09 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 10.34 | 67.20 | 1.86 | 7.44 | 1.03 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 11.00 | 98.58 | 2.59 | 10.35 | 1.08 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 11.95 | 83.78 | 4.70 | 10.25 | 0.85 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 327.07 | 156.72 | 57.29 | 12.43 | 1.21 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 226.35 | 256.31 | 121.50 | 9.99 | 8.32 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 270.64 | 252.80 | 86.18 | 12.40 | 9.37 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 13.15 | 44.16 | 5.21 | 2.48 | 0.99 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 6.60 | 7.52 | 3.84 | 2.00 | 0.15 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 10.10 | 42.38 | 5.61 | 1.68 | 0.84 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 10.76 | 41.65 | 2.69 | 1.67 | 0.77 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 5.63 | 31.21 | 5.63 | 1.02 | 0.51 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 30.08 | 29.44 | 13.99 | 5.15 | 1.77 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 0.00 | 41.56 | 7.42 | 2.97 | 1.48 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 482.68 | 247.04 | 377.04 | 36.86 | 8.17 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 219.29 | 180.05 | 135.12 | 24.68 | 11.01 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 341.65 | 161.46 | 402.75 | 44.60 | 11.01 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 208.22 | 380.61 | 345.82 | 33.75 | 12.46 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 268.10 | 143.52 | 434.39 | 42.65 | 11.16 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 132.58 | 122.55 | 6.41 | 4.83 | 5.68 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 73.79 | 74.59 | 21.25 | 7.82 | 1.80 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 310.50 | 260.68 | 27.35 | 10.04 | 4.97 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 221.71 | 96.79 | 130.89 | 13.32 | 4.25 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 514.95 | 179.00 | 382.39 | 27.68 | 6.74 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 168.89 | 116.31 | 94.93 | 9.44 | 6.03 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 1564.31 | 476.02 | 674.09 | 36.55 | 8.12 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 884.83 | 331.94 | 317.53 | 14.71 | 3.77 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 2298.14 | 938.08 | 995.34 | 80.79 | 14.12 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 929.45 | 428.19 | 873.91 | 70.15 | 13.15 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 808.21 | 404.90 | 268.42 | 14.67 | 7.39 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 379.87 | 274.10 | 446.97 | 31.85 | 1.14 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 634.11 | 224.35 | 627.31 | 26.53 | 5.44 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 376.77 | 155.03 | 228.22 | 23.53 | 2.59 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 453.43 | 485.82 | 316.17 | 21.59 | 10.80 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 835.06 | 304.54 | 485.27 | 41.73 | 11.38 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 873.44 | 489.65 | 214.72 | 26.59 | 13.55 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 1171.16 | 302.54 | 708.05 | 37.47 | 13.25 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 1026.38 | 359.86 | 712.23 | 39.89 | 9.14 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 1583.69 | 399.84 | 803.71 | 53.95 | 19.92 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 93.84 | 176.28 | 3.29 | 1.75 | 2.41 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 60.91 | 142.48 | 2.09 | 3.66 | 1.57 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 1424.32 | 149.77 | 394.93 | 15.39 | 7.44 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 766.90 | 283.40 | 109.23 | 20.99 | 12.79 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 368.65 | 333.19 | 376.79 | 20.17 | 6.83 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 32.77 | 37.20 | 3.81 | 2.58 | 1.44 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 18.77 | 63.55 | 6.04 | 6.14 | 0.82 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 11.30 | 46.62 | 5.12 | 3.71 | 1.16 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 244.06 | 276.80 | 83.27 | 25.27 | 8.04 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 239.87 | 314.63 | 54.61 | 16.90 | 8.45 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 61.06 | 57.85 | 17.68 | 14.46 | 1.61 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 802.27 | 468.47 | 277.06 | 33.54 | 10.63 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 408.38 | 156.21 | 299.32 | 22.18 | 5.85 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 339.40 | 172.38 | 203.24 | 15.20 | 7.21 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 465.06 | 176.84 | 518.95 | 25.36 | 3.86 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 532.70 | 198.83 | 90.02 | 10.42 | 3.12 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 488.85 | 188.09 | 139.65 | 11.46 | 3.19 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 711.47 | 192.27 | 504.29 | 24.29 | 7.33 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 45.05 | 75.94 | 6.05 | 5.88 | 2.23 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 115.37 | 131.90 | 18.84 | 7.27 | 2.98 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 168.74 | 124.73 | 31.90 | 14.03 | 1.92 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 43.52 | 27.95 | 9.44 | 2.81 | 3.70 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 182.99 | 175.10 | 20.13 | 11.94 | 2.73 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 123.65 | 318.42 | 107.84 | 34.86 | 12.55 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 45.33 | 63.91 | 50.68 | 9.13 | 2.83 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 665.67 | 316.45 | 514.41 | 62.73 | 11.15 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 380.73 | 256.90 | 271.38 | 36.04 | 10.78 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 417.86 | 232.09 | 474.82 | 61.75 | 22.36 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 633.31 | 339.27 | 528.92 | 47.85 | 11.31 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 550.97 | 271.13 | 619.35 | 76.35 | 15.20 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 71.56 | 59.25 | 52.67 | 10.30 | 2.29 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 120.95 | 84.11 | 74.06 | 17.12 | 4.09 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 89.54 | 92.70 | 37.33 | 10.76 | 5.69 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 39.08 | 71.68 | 9.15 | 4.38 | 2.86 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 1055.58 | 322.43 | 717.54 | 53.23 | 40.18 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 177.59 | 115.54 | 56.49 | 4.71 | 8.56 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 971.79 | 375.80 | 727.09 | 72.87 | 22.59 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 342.24 | 311.62 | 368.14 | 56.52 | 15.70 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 132.39 | 98.39 | 28.60 | 4.86 | 4.68 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 178.45 | 146.88 | 34.32 | 8.51 | 4.39 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 308.32 | 145.85 | 92.01 | 12.02 | 6.24 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 530.12 | 258.39 | 529.11 | 74.40 | 20.02 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 320.19 | 228.25 | 451.75 | 68.16 | 25.36 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 252.76 | 190.83 | 163.03 | 33.70 | 8.00 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 528.59 | 338.42 | 125.81 | 27.80 | 17.07 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 388.24 | 152.81 | 257.36 | 21.45 | 13.16 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 131.01 | 354.98 | 333.85 | 61.28 | 22.19 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 155.61 | 86.27 | 195.19 | 21.98 | 5.73 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 153.14 | 103.23 | 35.07 | 8.20 | 5.51 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 901.80 | 441.86 | 767.33 | 64.41 | 20.34 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 406.36 | 373.83 | 375.48 | 56.79 | 12.13 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 330.39 | 201.69 | 429.25 | 41.80 | 12.61 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 226.68 | 134.17 | 323.58 | 46.48 | 12.72 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 680.06 | 216.46 | 532.47 | 53.25 | 48.04 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 467.00 | 207.26 | 98.38 | 12.46 | 10.49 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 401.97 | 235.98 | 332.37 | 51.13 | 10.55 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 558.92 | 248.17 | 426.63 | 50.19 | 8.37 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 492.69 | 294.09 | 414.66 | 53.52 | 8.45 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 856.17 | 266.60 | 229.60 | 25.10 | 17.35 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 162.01 | 152.38 | 22.20 | 4.42 | 5.60 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 426.94 | 215.43 | 352.39 | 56.35 | 9.99 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 634.67 | 267.49 | 777.28 | 59.60 | 9.22 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 40.32 | 76.00 | 10.13 | 3.59 | 2.74 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 26.01 | 58.94 | 11.53 | 3.29 | 1.65 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 559.34 | 292.95 | 1811.98 | 93.35 | 17.46 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 569.69 | 377.58 | 1027.41 | 75.59 | 12.25 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 606.58 | 397.88 | 75.25 | 23.96 | 3.27 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 931.72 | 488.65 | 152.16 | 30.83 | 4.69 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 316.87 | 479.12 | 92.56 | 45.73 | 2.18 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 35.30 | 33.99 | 4.14 | 3.30 | 1.41 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 179.95 | 211.81 | 36.59 | 13.78 | 3.01 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 119.61 | 165.10 | 23.59 | 6.74 | 3.37 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 200.43 | 303.31 | 27.94 | 9.76 | 2.22 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 241.67 | 227.89 | 32.39 | 8.27 | 1.61 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 7.10 | 47.19 | 0.51 | 1.01 | 1.01 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 2.29 | 35.94 | 0.00 | 3.06 | 1.53 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 7.41 | 69.50 | 2.28 | 3.99 | 0.57 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 7.39 | 52.17 | 0.95 | 5.00 | 1.19 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 7.82 | 63.35 | 1.65 | 2.88 | 1.23 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 1.95 | 30.48 | 1.30 | 1.95 | 0.00 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 3.78 | 43.74 | 1.08 | 1.08 | 2.16 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 8.72 | 72.17 | 2.38 | 4.76 | 2.38 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 410.31 | 175.51 | 198.80 | 28.95 | 3.85 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 37.54 | 141.48 | 11.55 | 8.66 | 7.70 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 456.26 | 468.27 | 37.98 | 28.18 | 1.72 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 239.31 | 196.95 | 136.75 | 141.77 | 9.48 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 64.63 | 60.02 | 153.65 | 84.83 | 3.46 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 291.40 | 206.67 | 18.92 | 8.89 | 12.66 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 168.19 | 163.09 | 28.06 | 5.10 | 5.58 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 286.20 | 406.74 | 34.33 | 34.33 | 4.19 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 47.30 | 142.10 | 3.45 | 12.26 | 2.11 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 132.30 | 312.01 | 15.45 | 32.39 | 1.48 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 200.29 | 392.79 | 28.57 | 4.22 | 1.30 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 43.24 | 238.40 | 2.81 | 6.74 | 3.09 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 154.97 | 120.96 | 26.70 | 55.92 | 6.62 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 254.29 | 626.41 | 23.97 | 23.03 | 4.07 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 52.63 | 258.15 | 5.01 | 7.52 | 27.57 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 326.06 | 331.30 | 29.96 | 9.48 | 3.89 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 134.25 | 417.53 | 29.07 | 137.95 | 3.05 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 157.61 | 326.31 | 36.73 | 139.24 | 2.02 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 61.32 | 156.29 | 10.65 | 99.65 | 3.41 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 31.26 | 104.08 | 4.47 | 33.32 | 6.18 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 140.41 | 157.00 | 82.34 | 236.58 | 5.22 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 121.90 | 137.11 | 75.60 | 212.94 | 6.71 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 165.01 | 172.52 | 95.60 | 236.76 | 6.17 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 236.03 | 477.72 | 25.40 | 59.59 | 15.83 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 254.74 | 326.01 | 43.15 | 14.20 | 5.85 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 105.86 | 232.64 | 16.00 | 19.69 | 7.39 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 90.06 | 243.41 | 10.28 | 5.95 | 1.08 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 52.96 | 245.47 | 4.00 | 12.32 | 6.00 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 33.84 | 66.26 | 2.82 | 15.51 | 4.23 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 181.53 | 213.34 | 11.23 | 5.24 | 9.36 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 16.56 | 44.83 | 4.10 | 6.45 | 0.59 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 150.97 | 189.32 | 22.57 | 6.92 | 2.55 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 62.07 | 246.62 | 3.79 | 24.41 | 3.68 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 481.33 | 257.43 | 199.75 | 35.52 | 15.91 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 62.07 | 89.53 | 4.30 | 1.67 | 0.95 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 45.14 | 68.00 | 3.27 | 1.48 | 2.67 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 38.40 | 117.34 | 1.23 | 0.92 | 0.31 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 3.98 | 61.64 | 2.98 | 1.99 | 1.99 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 6.75 | 37.56 | 1.55 | 3.80 | 1.97 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 1339.71 | 206.48 | 332.15 | 21.26 | 6.79 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 473.65 | 344.60 | 50.59 | 15.49 | 2.31 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 11.19 | 63.13 | 1.06 | 5.70 | 6.76 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 8.77 | 23.11 | 3.19 | 2.19 | 0.60 |
appendix, adult.CNhs12842.10189-103D9 | 47.52 | 93.66 | 17.96 | 10.50 | 3.87 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 193.74 | 436.35 | 18.64 | 7.81 | 15.62 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 198.71 | 155.45 | 38.56 | 16.77 | 11.05 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 221.43 | 303.40 | 75.57 | 115.08 | 3.82 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 98.91 | 94.56 | 95.49 | 15.55 | 3.73 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 644.36 | 113.14 | 557.27 | 27.86 | 6.20 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 148.23 | 67.13 | 14.50 | 5.19 | 4.30 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 86.46 | 170.35 | 18.93 | 76.22 | 2.56 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 11.54 | 37.29 | 1.68 | 0.69 | 0.79 |
blood, adult, pool1.CNhs11761.10053-101G8 | 2.39 | 59.87 | 7.18 | 7.18 | 2.39 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 55.57 | 95.58 | 27.78 | 22.23 | 10.00 |
brain, adult, donor1.CNhs11796.10084-102B3 | 2.91 | 51.37 | 1.94 | 2.91 | 0.00 |
brain, adult, pool1.CNhs10617.10012-101C3 | 3.53 | 51.39 | 1.48 | 3.43 | 0.37 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 3.99 | 121.76 | 0.00 | 0.00 | 3.99 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 54.43 | 84.12 | 4.69 | 7.03 | 4.95 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 73.03 | 54.92 | 8.13 | 8.57 | 3.59 |
breast, adult, donor1.CNhs11792.10080-102A8 | 17.40 | 34.80 | 4.35 | 5.07 | 0.00 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 251.94 | 73.28 | 54.05 | 6.60 | 11.61 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 477.74 | 157.89 | 60.26 | 19.07 | 2.03 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 103.07 | 124.34 | 10.87 | 17.02 | 4.25 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 125.83 | 233.39 | 25.86 | 11.03 | 10.00 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 117.23 | 332.43 | 12.25 | 13.71 | 10.21 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 34.55 | 153.31 | 6.94 | 2.08 | 5.21 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 7.97 | 36.32 | 1.77 | 4.43 | 0.00 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 5.07 | 39.44 | 1.45 | 2.17 | 0.60 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 4.58 | 50.35 | 0.00 | 3.05 | 0.00 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 6.08 | 40.69 | 0.77 | 1.88 | 0.66 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 5.62 | 39.31 | 0.89 | 2.96 | 0.89 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 1.54 | 36.64 | 1.10 | 1.97 | 0.66 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 59.04 | 111.34 | 11.77 | 18.63 | 33.99 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 80.45 | 82.26 | 15.34 | 8.09 | 4.88 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 16.70 | 24.78 | 1.39 | 2.15 | 0.54 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 17.09 | 36.69 | 4.10 | 1.71 | 0.34 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 574.57 | 158.63 | 43.35 | 17.29 | 5.30 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 1042.89 | 346.46 | 38.87 | 20.11 | 9.16 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 556.17 | 120.49 | 19.77 | 6.41 | 5.43 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 13.40 | 27.43 | 0.96 | 1.60 | 0.32 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 173.49 | 77.95 | 32.24 | 9.34 | 3.11 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 9.06 | 23.99 | 0.53 | 0.00 | 0.00 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 128.76 | 149.20 | 123.65 | 17.37 | 3.07 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 377.38 | 282.41 | 30.14 | 18.37 | 5.81 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 132.47 | 168.21 | 28.26 | 29.59 | 6.48 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 576.40 | 914.34 | 69.71 | 20.53 | 13.31 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 627.60 | 947.96 | 58.23 | 20.39 | 12.55 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 780.20 | 873.34 | 82.90 | 17.12 | 8.56 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 437.19 | 678.94 | 38.52 | 5.31 | 6.26 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 271.94 | 407.35 | 36.87 | 23.36 | 3.97 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 282.53 | 324.94 | 97.90 | 9.28 | 5.91 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 306.39 | 182.98 | 23.18 | 7.51 | 7.51 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 134.85 | 98.66 | 7.07 | 2.54 | 4.10 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 150.39 | 267.02 | 12.12 | 11.68 | 30.51 |
colon, adult, donor1.CNhs11794.10082-102B1 | 47.77 | 89.57 | 4.98 | 1.99 | 1.99 |
colon, adult, pool1.CNhs10619.10014-101C5 | 28.75 | 66.34 | 3.18 | 1.95 | 1.33 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 36.66 | 73.93 | 0.00 | 2.44 | 0.00 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 37.66 | 47.74 | 3.56 | 5.34 | 1.78 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 83.41 | 97.86 | 14.21 | 24.09 | 2.72 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 102.65 | 98.78 | 14.62 | 27.78 | 1.04 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 5.39 | 18.20 | 2.36 | 3.10 | 0.67 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 12.04 | 10.43 | 0.80 | 3.21 | 0.80 |
diencephalon, adult.CNhs12610.10193-103E4 | 3.98 | 35.84 | 1.41 | 3.28 | 1.17 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 144.14 | 250.69 | 114.03 | 98.89 | 5.29 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 186.47 | 199.38 | 35.02 | 21.13 | 18.59 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 665.70 | 222.63 | 158.54 | 17.48 | 9.71 |
ductus deferens, adult.CNhs12846.10196-103E7 | 5.13 | 31.17 | 1.58 | 0.39 | 1.18 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 22.99 | 84.69 | 2.42 | 1.21 | 0.00 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 16.53 | 129.77 | 5.82 | 3.06 | 1.22 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 8.47 | 27.17 | 3.16 | 18.45 | 1.26 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 30.82 | 63.29 | 43.29 | 9.62 | 1.05 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 70.61 | 102.44 | 37.85 | 12.55 | 1.66 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 928.52 | 190.09 | 494.50 | 37.89 | 6.65 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 711.63 | 171.12 | 241.96 | 18.20 | 5.63 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 841.97 | 196.21 | 340.62 | 22.29 | 3.77 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 866.18 | 135.00 | 578.25 | 37.04 | 7.17 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 118.68 | 143.44 | 31.02 | 13.95 | 18.50 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 101.51 | 108.44 | 17.06 | 3.74 | 2.91 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 126.87 | 172.69 | 29.85 | 7.98 | 1.39 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 496.23 | 327.78 | 46.55 | 15.78 | 5.49 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 512.17 | 207.55 | 109.78 | 30.21 | 2.79 |
epididymis, adult.CNhs12847.10197-103E8 | 7.69 | 24.11 | 0.52 | 1.57 | 1.57 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 72.06 | 88.06 | 11.87 | 2.41 | 0.86 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 214.12 | 114.08 | 50.22 | 15.29 | 3.87 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 243.46 | 115.48 | 42.61 | 18.35 | 5.41 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 242.08 | 121.94 | 58.96 | 21.19 | 4.93 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 98.44 | 88.65 | 4.46 | 4.75 | 1.55 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 70.43 | 141.12 | 29.65 | 8.74 | 1.41 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 15.59 | 43.61 | 3.62 | 4.97 | 1.13 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 607.78 | 189.25 | 339.59 | 27.68 | 3.15 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 353.91 | 270.45 | 219.98 | 45.31 | 13.71 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 3.61 | 49.19 | 1.20 | 4.24 | 0.70 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 36.57 | 46.35 | 11.54 | 3.32 | 6.84 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 470.69 | 314.22 | 197.99 | 19.72 | 7.29 |
gall bladder, adult.CNhs12848.10198-103E9 | 28.82 | 49.73 | 3.63 | 1.28 | 1.92 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 13.19 | 21.78 | 8.99 | 1.40 | 1.60 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 290.34 | 243.08 | 23.92 | 11.09 | 2.74 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 427.68 | 280.73 | 205.59 | 22.33 | 6.99 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 175.03 | 264.08 | 13.56 | 5.66 | 5.49 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 322.97 | 599.70 | 105.45 | 20.89 | 12.96 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 1367.52 | 339.09 | 262.05 | 11.06 | 10.93 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 80.14 | 91.68 | 12.49 | 7.07 | 5.66 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 24.87 | 29.49 | 15.63 | 9.92 | 4.89 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 30.33 | 34.83 | 14.02 | 10.56 | 7.22 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 23.26 | 66.60 | 35.09 | 23.15 | 8.57 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 134.65 | 164.70 | 13.29 | 6.93 | 10.40 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 5.40 | 22.82 | 4.20 | 1.20 | 1.20 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 8.63 | 24.37 | 3.83 | 4.38 | 0.82 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 12.77 | 49.82 | 7.66 | 17.88 | 21.72 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 118.62 | 172.77 | 27.08 | 9.45 | 7.31 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 27.08 | 99.90 | 2.89 | 17.61 | 1.05 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 3.07 | 10.61 | 0.56 | 2.23 | 0.84 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 8.71 | 20.40 | 0.46 | 3.67 | 0.69 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 5.03 | 7.90 | 2.15 | 1.44 | 0.00 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 57.31 | 97.64 | 8.99 | 3.00 | 1.80 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 10.73 | 38.20 | 0.86 | 2.15 | 0.86 |
heart, adult, pool1.CNhs10621.10016-101C7 | 20.09 | 36.60 | 2.45 | 5.80 | 2.01 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 19.75 | 33.39 | 2.82 | 4.10 | 0.60 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 18.01 | 48.28 | 7.93 | 2.88 | 2.88 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 357.64 | 342.50 | 22.13 | 6.99 | 13.98 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 290.55 | 222.40 | 27.50 | 8.04 | 6.93 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 268.43 | 209.09 | 25.71 | 7.50 | 6.02 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 292.06 | 234.16 | 23.12 | 8.36 | 9.71 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 97.25 | 81.20 | 15.06 | 10.43 | 2.85 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 322.69 | 211.60 | 65.28 | 109.65 | 10.67 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 2.39 | 31.01 | 2.39 | 0.80 | 0.00 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 6.40 | 32.14 | 2.72 | 3.54 | 1.09 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 960.34 | 620.51 | 55.46 | 7.88 | 4.18 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 1151.34 | 654.14 | 65.61 | 9.63 | 6.19 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 865.36 | 684.65 | 59.41 | 10.39 | 4.15 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 18.67 | 92.01 | 3.15 | 11.92 | 0.67 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 31.73 | 68.09 | 6.96 | 13.15 | 3.10 |
insula, adult, pool1.CNhs10646.10039-101F3 | 4.43 | 61.54 | 2.31 | 4.19 | 1.46 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 57.36 | 86.88 | 6.71 | 9.73 | 6.04 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 13.95 | 20.02 | 2.13 | 1.97 | 0.32 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 40.18 | 58.80 | 3.57 | 2.78 | 1.68 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 418.49 | 173.50 | 922.42 | 44.04 | 8.76 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 62.93 | 120.84 | 7.89 | 5.38 | 7.89 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 261.58 | 140.48 | 75.04 | 10.75 | 21.30 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 10.01 | 44.31 | 2.14 | 1.43 | 0.71 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 12.58 | 32.44 | 1.99 | 1.32 | 2.65 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 71.70 | 154.60 | 16.53 | 8.39 | 2.54 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 286.70 | 177.02 | 402.36 | 36.38 | 41.27 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 88.15 | 100.25 | 148.65 | 24.20 | 18.15 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 360.23 | 187.79 | 463.75 | 44.74 | 41.15 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 105.36 | 171.21 | 173.61 | 44.30 | 16.76 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 159.51 | 371.96 | 20.61 | 15.11 | 1.64 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 16.19 | 35.27 | 4.60 | 2.39 | 2.22 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 145.38 | 68.78 | 143.23 | 33.20 | 7.03 |
liver, adult, pool1.CNhs10624.10018-101C9 | 3.37 | 13.63 | 0.29 | 1.03 | 0.00 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 123.23 | 107.33 | 15.90 | 6.63 | 1.33 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 16.94 | 40.85 | 8.53 | 2.84 | 2.59 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 8.73 | 24.07 | 2.12 | 2.64 | 1.32 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 301.80 | 139.78 | 29.60 | 7.19 | 4.28 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 1025.51 | 401.04 | 211.44 | 46.52 | 26.08 |
lung, adult, pool1.CNhs10625.10019-101D1 | 28.19 | 55.10 | 6.94 | 4.06 | 0.64 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 9.12 | 46.22 | 1.26 | 1.26 | 0.47 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 3.73 | 21.54 | 0.83 | 3.31 | 0.41 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 19.85 | 74.42 | 5.95 | 8.93 | 0.50 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 64.22 | 119.95 | 31.03 | 74.70 | 0.99 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 116.92 | 199.50 | 142.38 | 158.45 | 4.26 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 125.11 | 158.95 | 27.45 | 16.60 | 5.75 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 8.70 | 16.32 | 0.54 | 1.63 | 1.63 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 7.77 | 20.06 | 1.50 | 0.50 | 0.25 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 15.93 | 20.53 | 3.06 | 0.61 | 0.31 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 8.85 | 22.95 | 0.66 | 2.30 | 1.31 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 64.86 | 177.00 | 3.61 | 8.64 | 3.14 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 6.20 | 53.16 | 4.43 | 3.54 | 1.77 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 7.93 | 78.10 | 3.78 | 3.05 | 1.34 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 6.38 | 42.94 | 1.00 | 2.38 | 1.00 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 8.60 | 21.22 | 4.59 | 1.72 | 0.57 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 8.99 | 22.07 | 4.10 | 3.00 | 0.89 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 7.39 | 31.79 | 3.04 | 4.35 | 1.92 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 102.24 | 131.15 | 17.57 | 20.89 | 11.48 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 159.10 | 114.61 | 109.23 | 25.12 | 13.75 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 40.49 | 52.02 | 28.51 | 12.13 | 4.70 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 13.70 | 68.80 | 6.57 | 12.85 | 8.85 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 1119.39 | 104.69 | 1299.14 | 33.17 | 8.47 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 122.70 | 197.64 | 72.12 | 19.20 | 23.89 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 79.27 | 74.20 | 35.36 | 12.90 | 6.38 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 205.37 | 167.91 | 62.54 | 17.91 | 9.70 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 119.89 | 205.20 | 10.52 | 6.54 | 11.45 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 150.35 | 233.02 | 82.11 | 21.64 | 8.32 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 385.06 | 291.87 | 87.13 | 19.89 | 13.64 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 138.61 | 233.96 | 16.35 | 7.55 | 11.82 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 156.61 | 190.42 | 75.63 | 16.91 | 11.57 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 210.76 | 209.39 | 33.41 | 9.61 | 7.55 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 288.55 | 258.30 | 41.29 | 9.83 | 11.95 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 128.24 | 155.59 | 28.29 | 14.77 | 6.37 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 158.94 | 111.19 | 56.48 | 13.75 | 7.24 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 341.69 | 171.24 | 75.67 | 12.11 | 5.10 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 353.55 | 365.24 | 180.37 | 27.44 | 19.34 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 188.96 | 168.77 | 32.61 | 11.33 | 7.45 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 471.52 | 285.32 | 156.76 | 23.64 | 12.44 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 292.16 | 220.12 | 60.08 | 10.37 | 6.38 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 214.44 | 189.92 | 88.70 | 23.48 | 7.83 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 207.05 | 258.59 | 19.83 | 4.96 | 10.07 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 272.28 | 139.37 | 123.00 | 21.33 | 12.19 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 126.13 | 125.32 | 113.11 | 16.68 | 1.63 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 173.12 | 169.66 | 37.64 | 14.00 | 6.73 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 405.26 | 249.19 | 55.96 | 13.75 | 10.63 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 409.74 | 367.51 | 83.99 | 14.39 | 7.89 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 231.69 | 198.25 | 107.88 | 19.51 | 7.56 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 46.00 | 86.01 | 14.00 | 5.60 | 3.60 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 95.46 | 122.25 | 53.57 | 10.99 | 2.06 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 92.27 | 138.07 | 55.23 | 11.45 | 2.69 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 13.88 | 26.50 | 10.09 | 2.52 | 0.00 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 189.54 | 254.64 | 17.91 | 7.70 | 4.62 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 67.12 | 83.20 | 10.29 | 6.22 | 4.72 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 352.08 | 261.78 | 141.20 | 34.45 | 8.87 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 73.91 | 109.27 | 28.79 | 15.42 | 7.93 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 217.40 | 183.60 | 117.61 | 29.63 | 7.64 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 395.74 | 146.35 | 266.76 | 25.21 | 12.48 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 154.91 | 125.00 | 53.19 | 19.34 | 8.06 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 122.29 | 240.56 | 14.82 | 7.72 | 14.20 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 30.04 | 81.79 | 10.09 | 8.33 | 5.70 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 258.14 | 105.84 | 174.75 | 19.97 | 4.42 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 493.09 | 174.59 | 385.06 | 47.26 | 6.94 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 268.45 | 163.87 | 89.71 | 31.42 | 16.05 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 18.19 | 76.10 | 3.33 | 4.36 | 4.36 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 123.66 | 141.63 | 25.22 | 16.58 | 4.49 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 484.66 | 243.39 | 240.66 | 24.00 | 23.70 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 6.77 | 37.88 | 1.80 | 3.32 | 0.83 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 4.87 | 41.70 | 4.29 | 43.06 | 0.19 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 4.78 | 24.85 | 2.79 | 30.16 | 0.27 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 2.78 | 37.46 | 2.13 | 24.53 | 0.00 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 27.85 | 95.66 | 20.97 | 5.90 | 2.95 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 327.37 | 256.83 | 99.54 | 16.71 | 4.42 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 2044.23 | 253.79 | 1336.97 | 56.84 | 26.41 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 40.20 | 53.00 | 7.80 | 6.80 | 3.60 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 157.37 | 180.20 | 30.30 | 45.45 | 6.61 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 4.65 | 14.81 | 2.76 | 8.27 | 0.17 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 413.15 | 203.17 | 104.99 | 14.19 | 6.24 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 149.13 | 144.71 | 194.42 | 37.74 | 2.03 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 413.06 | 292.07 | 16.93 | 5.74 | 2.10 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 199.69 | 228.30 | 22.39 | 6.84 | 1.87 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 176.24 | 449.80 | 7.55 | 20.21 | 26.73 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 12.18 | 66.10 | 11.32 | 7.98 | 3.88 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 23.43 | 99.71 | 9.12 | 19.82 | 4.72 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 43.36 | 205.75 | 70.22 | 18.35 | 5.68 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 172.79 | 262.07 | 21.56 | 6.79 | 11.54 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 39.33 | 184.09 | 3.83 | 2.76 | 7.01 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 5.70 | 48.09 | 2.48 | 1.49 | 1.98 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 92.18 | 248.60 | 24.02 | 13.41 | 56.98 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 46.11 | 56.92 | 26.08 | 8.90 | 5.72 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 24.84 | 87.69 | 24.21 | 21.92 | 7.73 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 15.21 | 25.62 | 1.60 | 2.40 | 8.81 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 43.73 | 38.79 | 69.12 | 7.05 | 2.12 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 24.50 | 40.12 | 25.42 | 7.96 | 3.06 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 4.88 | 53.05 | 1.16 | 3.60 | 1.09 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 2.83 | 48.18 | 1.42 | 1.42 | 0.00 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 7.82 | 34.64 | 2.55 | 3.35 | 0.64 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 2.67 | 45.13 | 0.62 | 4.10 | 0.41 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 4.79 | 98.31 | 0.50 | 1.26 | 0.25 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 4.70 | 67.64 | 1.45 | 5.12 | 1.45 |
olfactory region, adult.CNhs12611.10195-103E6 | 2.75 | 33.91 | 1.13 | 3.23 | 1.13 |
optic nerve, donor1.CNhs13449.10277-104E7 | 2.86 | 12.85 | 1.43 | 4.28 | 0.00 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 152.52 | 114.54 | 9.13 | 4.32 | 2.85 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 180.38 | 198.43 | 9.67 | 5.43 | 4.01 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 179.39 | 170.77 | 51.91 | 22.93 | 4.95 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 971.92 | 730.58 | 86.18 | 20.10 | 6.47 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 9.15 | 33.18 | 5.72 | 3.05 | 0.00 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 1268.88 | 405.93 | 1537.43 | 136.00 | 10.36 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 85.34 | 152.77 | 21.48 | 16.11 | 3.78 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 4.66 | 12.48 | 0.68 | 1.50 | 0.08 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 33.89 | 64.14 | 8.67 | 4.03 | 0.61 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 7.82 | 42.20 | 0.00 | 0.00 | 2.34 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 1188.27 | 168.67 | 54.74 | 12.05 | 3.40 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 168.03 | 105.31 | 373.56 | 42.74 | 7.70 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 1299.65 | 164.86 | 227.85 | 14.34 | 4.73 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 3.58 | 50.99 | 1.42 | 3.11 | 1.15 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 6.25 | 40.62 | 3.12 | 1.56 | 0.78 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 3.51 | 45.26 | 2.07 | 1.03 | 0.83 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 3.74 | 45.34 | 1.14 | 4.31 | 1.40 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 6.56 | 100.10 | 2.19 | 0.55 | 0.55 |
parotid gland, adult.CNhs12849.10199-103F1 | 10.97 | 51.54 | 1.64 | 2.74 | 0.00 |
penis, adult.CNhs12850.10200-103F2 | 10.92 | 24.81 | 1.98 | 0.50 | 0.50 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 20.75 | 180.27 | 1.93 | 1.58 | 2.81 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 135.17 | 81.38 | 44.08 | 12.90 | 4.09 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 7.50 | 25.18 | 2.14 | 5.36 | 1.61 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 10.09 | 33.29 | 1.01 | 2.69 | 1.01 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 3.64 | 13.96 | 0.00 | 0.61 | 0.61 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 0.68 | 14.57 | 0.00 | 0.68 | 0.23 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 73.89 | 41.87 | 7.27 | 6.56 | 2.66 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 73.29 | 224.71 | 42.06 | 76.63 | 3.34 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 84.89 | 114.21 | 21.26 | 7.55 | 8.06 |
pons, adult, pool1.CNhs10640.10033-101E6 | 8.02 | 43.98 | 1.90 | 4.96 | 0.95 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 4.74 | 64.65 | 1.71 | 4.67 | 0.86 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 167.13 | 157.79 | 35.34 | 8.27 | 6.97 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 527.35 | 83.76 | 464.95 | 28.81 | 13.24 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 6.20 | 24.41 | 1.73 | 1.18 | 0.55 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 6.44 | 50.59 | 3.30 | 1.41 | 0.63 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 623.89 | 292.88 | 25.50 | 5.89 | 6.17 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 14.61 | 45.66 | 0.91 | 1.83 | 0.91 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 15.98 | 43.83 | 4.32 | 4.75 | 0.86 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 19.11 | 139.03 | 5.73 | 1.91 | 4.78 |
retina, adult, pool1.CNhs10636.10030-101E3 | 10.08 | 32.88 | 2.22 | 5.22 | 2.36 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 473.25 | 459.03 | 33.34 | 24.02 | 16.43 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 86.83 | 68.35 | 8.37 | 5.11 | 2.32 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 139.26 | 173.34 | 37.73 | 22.95 | 5.91 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 194.01 | 135.49 | 99.41 | 11.22 | 2.41 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 29.01 | 89.72 | 3.11 | 3.73 | 1.86 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 2.05 | 48.83 | 0.00 | 1.37 | 0.34 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 16.59 | 40.78 | 0.00 | 0.69 | 0.69 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 3.87 | 48.62 | 3.01 | 2.15 | 1.29 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 685.14 | 309.44 | 184.95 | 27.57 | 17.28 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 789.42 | 365.74 | 209.11 | 31.36 | 17.89 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 3.81 | 26.25 | 1.27 | 0.85 | 1.69 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 90.96 | 74.69 | 35.97 | 6.41 | 5.73 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 204.74 | 179.92 | 56.77 | 15.20 | 2.79 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 315.33 | 142.38 | 223.60 | 25.80 | 3.82 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 56.26 | 139.04 | 3.36 | 3.36 | 1.90 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 373.27 | 184.42 | 111.60 | 19.53 | 12.07 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 392.33 | 139.47 | 109.97 | 16.09 | 9.63 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 30.43 | 10.36 | 3.24 | 2.59 | 1.29 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 57.49 | 29.87 | 5.03 | 6.06 | 1.44 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 83.51 | 54.51 | 15.08 | 5.80 | 2.32 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 27.20 | 58.29 | 3.40 | 0.49 | 1.94 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 66.20 | 38.37 | 19.42 | 4.68 | 3.98 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 21.88 | 94.90 | 6.57 | 3.58 | 4.18 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 10.58 | 69.33 | 3.09 | 2.97 | 6.18 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 77.37 | 82.90 | 36.71 | 26.54 | 12.76 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 130.94 | 414.70 | 35.95 | 16.27 | 9.56 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 40.31 | 40.91 | 30.65 | 10.57 | 6.94 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 44.99 | 92.69 | 4.17 | 1.85 | 2.24 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 54.42 | 115.18 | 4.81 | 3.28 | 1.53 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 50.32 | 162.26 | 12.23 | 6.58 | 7.05 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 0.98 | 5.88 | 0.25 | 0.25 | 0.00 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 21.92 | 103.70 | 3.77 | 8.48 | 7.31 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 7.46 | 25.72 | 3.14 | 2.55 | 1.37 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 13.96 | 25.84 | 2.67 | 3.27 | 1.19 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 6.76 | 35.93 | 2.96 | 4.65 | 1.69 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 165.17 | 93.63 | 116.06 | 19.88 | 8.16 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 43.23 | 62.41 | 16.17 | 16.45 | 0.28 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 72.45 | 103.13 | 11.80 | 12.50 | 0.71 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 27.98 | 72.16 | 24.09 | 56.97 | 1.40 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 102.13 | 111.95 | 12.32 | 4.46 | 2.32 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 407.24 | 152.80 | 185.27 | 8.12 | 3.88 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 247.46 | 109.45 | 120.20 | 18.94 | 4.41 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 46.01 | 74.49 | 10.96 | 2.92 | 1.46 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 10.55 | 43.12 | 2.75 | 1.38 | 2.75 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 7.45 | 19.06 | 2.72 | 2.29 | 0.72 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 7.57 | 36.76 | 3.79 | 7.10 | 0.00 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 5.44 | 72.14 | 2.04 | 4.69 | 1.16 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 4.80 | 111.27 | 1.31 | 5.24 | 1.31 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 15.87 | 79.35 | 5.29 | 2.65 | 3.70 |
tenocyte, donor1.CNhs12639.11763-123H8 | 43.15 | 81.09 | 18.97 | 6.32 | 3.35 |
tenocyte, donor2.CNhs12640.11765-123I1 | 19.41 | 38.36 | 10.63 | 0.92 | 1.39 |
tenocyte, donor3.CNhs12641.11768-123I4 | 80.04 | 77.44 | 54.94 | 9.09 | 6.49 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 866.64 | 398.56 | 122.51 | 9.46 | 3.41 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 487.32 | 293.05 | 59.88 | 14.31 | 15.52 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 252.76 | 180.55 | 7.60 | 2.66 | 4.43 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 871.60 | 333.40 | 62.21 | 8.67 | 1.94 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 984.70 | 940.87 | 34.47 | 9.62 | 2.94 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 2376.86 | 758.04 | 45.67 | 7.17 | 3.95 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 562.59 | 303.86 | 85.74 | 12.79 | 4.76 |
testis, adult, pool1.CNhs10632.10026-101D8 | 28.19 | 59.11 | 5.68 | 6.90 | 3.56 |
testis, adult, pool2.CNhs12998.10096-102C6 | 38.59 | 98.61 | 13.67 | 12.86 | 5.63 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 6.63 | 30.68 | 4.15 | 2.49 | 1.66 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 8.79 | 19.96 | 3.52 | 2.69 | 0.62 |
throat, adult.CNhs12858.10209-103G2 | 57.15 | 66.10 | 3.41 | 2.56 | 2.35 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 33.09 | 35.00 | 2.38 | 0.95 | 1.90 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 174.20 | 199.13 | 8.59 | 5.88 | 4.00 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 174.80 | 159.10 | 8.63 | 5.65 | 5.34 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 542.61 | 240.75 | 463.67 | 26.01 | 11.44 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 13.30 | 37.30 | 1.21 | 0.64 | 0.45 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 14.35 | 25.67 | 0.81 | 0.61 | 1.62 |
tongue, adult.CNhs12853.10203-103F5 | 61.18 | 97.75 | 5.01 | 5.44 | 1.52 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 35.93 | 41.41 | 3.08 | 3.76 | 2.40 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 119.75 | 147.97 | 16.70 | 18.93 | 2.29 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 51.28 | 69.14 | 5.74 | 3.37 | 1.43 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 19.96 | 30.60 | 3.66 | 0.33 | 1.00 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 261.14 | 107.05 | 92.96 | 17.01 | 7.57 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 396.39 | 189.55 | 178.55 | 10.25 | 5.44 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 334.02 | 83.02 | 243.27 | 23.17 | 11.58 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 1385.91 | 184.86 | 1563.86 | 48.33 | 18.77 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 16.42 | 63.35 | 2.35 | 0.00 | 0.00 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 3.06 | 16.14 | 1.10 | 0.98 | 0.61 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 17.09 | 27.26 | 0.81 | 1.22 | 0.81 |
vagina, adult.CNhs12854.10204-103F6 | 5.33 | 37.28 | 0.67 | 1.33 | 0.00 |
vein, adult.CNhs12844.10191-103E2 | 26.77 | 69.64 | 8.86 | 6.64 | 1.61 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 136.24 | 300.05 | 67.64 | 99.38 | 2.24 |